초음파 AI 수익화 동향 : 도입 지침, 워크플로우, 클라우드, 거버넌스(2024-2035년)

Report Overview

This Marketstrat® Focus Report examines how ultrasound AI is packaged, priced, reimbursed and captured across the global ultrasound ecosystem from 2024 through 2035. It reconciles to Marketstrat's ultrasound core model with developments refreshed through June 2026. Our view: monetization is shifting from scanner features to governed workflow infrastructure, and capture depends more on packaging and reimbursement position than on model quality.

Key Questions Answered

• Where does ultrasound AI value sit beyond the recurring software line?
• Which use cases are ready for scaled monetization, and which still need evidence?
• How do per-study, subscription, bundle and hybrid usage contracts compare on observed economics?
• What did the 2025–2026 coding and payment changes alter?

Market Snapshot

The report separates core AI recurring revenue, which sits inside ecosystem totals, from a broader AI value-pool bridge spanning hardware-linked AI, software, services and cloud or pay-per-use. The widening gap between them is value that transacts through bundles, upgrades and consumption. Cloud and pay-per-use grows fastest; software stays largest. North America anchors monetization quality, while China offers deployment scale with thinner recurring economics.

Key Market Trends

• 1. Value is migrating above the probe. The console becomes the platform for selling guidance, reporting automation and cloud review.
• 2. Reimbursement sets the price ceiling. The same capability prices near zero without a code and at a premium with one.
• 3. Payment moved from thesis to fact. First echo-AI payments and the first AI code family in CPT 2026 set public prices.
• 4. Case-finding outsells efficiency. Detecting missed, billable disease builds a more durable purchase case than productivity alone.
• 5. Embedding versus vendor-agnostic insertion is the structural fork. Feature-only vendors without a code or channel face absorption.

Competitive Structure

Competition is analyzed as five sub-battlegrounds, from guided acquisition to cloud review. The report maps control points, dates OEM moves by GE HealthCare, Philips, Samsung Medison and Siemens Healthineers, and profiles twelve vendors including Ultromics, UltraSight, Butterfly Network, Echo IQ and Koios Medical.

What's Inside

Revenue architecture: AI streams, capabilities, hardware segments and regions, with US and China views.

Markintel® frameworks: Solution Adoption & Growth Matrix, ARC-Index readiness scoring and the Upgrade & Package Ladder.

Pricing and reimbursement: Five commercial archetypes, an observed price ladder and four US payment pathways ranked by durability.

Playbooks and signposts: Six player-specific playbooks and dated signals for the next 12–24 months.

Who Should Read This Report

• Ultrasound OEM and handheld platform executives
• AI software founders and product leaders
• Workflow, reporting and enterprise imaging vendors
• Health systems and POCUS programs buying at fleet scale
• Investors and corporate-development teams

Why This Report

This report follows the money. It ties each use case to a buyer, contract form, ROI logic and reimbursement rung, and keeps every modeled figure traceable to one core model, showing which capabilities can carry scaled economics.

Table of Contents

1. EXECUTIVE SUMMARY

• 1.1 THE BOTTOM LINE
• 1.2 FIVE TAKEAWAYS

2. SCOPE, DEFINITIONS, AND METHODOLOGY

• 2.1 WHAT THIS REPORT IS
• 2.2 TWO AI LINES, DELIBERATELY SEPARATE
• 2.3 EVIDENCE BASE AND QA RULES

3. ULTRASOUND AI REVENUE ARCHITECTURE: CORE RECURRING VS THE TOTAL AI BRIDGE

• 3.1 SIZING THE POOL
• 3.2 THE MONETIZATION GAP AND HOW IT WIDENS
• 3.3 STREAM MECHANICS: WHY CLOUD WINS MIX
• 3.4 WHERE THE RECURRING DOLLARS ATTACH: CAPABILITIES, SEGMENTS, AND ARPU
• 3.5 THE ECOSYSTEM CONTEXT: VALUE MIGRATING ABOVE THE PROBE
• 3.6 REGIONAL ARCHITECTURE: WHERE THE BRIDGE MONETIZES (GLOBAL, WITH U.S. AND CHINA COLOR)

4. USE-CASE OPPORTUNITY MAP

5. COMMERCIAL READINESS: THE ARC-INDEX

6. MONETIZATION MODELS AND PRICING EVIDENCE

• 6.1 FIVE COMMERCIAL ARCHETYPES AND WHAT EACH ACTUALLY CLEARS
• 6.2 THE PRICING LADDER IN ONE VIEW
• 6.3 ROI EVIDENCE: WHAT BUYERS ACTUALLY REPORT
• 6.4 MATCHING CONTRACT TO USE CASE

7. REIMBURSEMENT ARCHITECTURE: THE GATING VARIABLE AND THE 2025–2026 INFLECTION

• 7.1 WHY REIMBURSEMENT GATES EVERYTHING
• 7.2 FOUR PATHWAYS, ASCENDING DURABILITY
• 7.3 WHAT CHANGED IN 2025–2026: FROM THEORY TO PAYMENT
• 7.4 IMPLICATIONS: PRICING POWER FOLLOWS THE RUNG

8. SCANNER-NATIVE VS WORKFLOW-NATIVE STRATEGY AND THE UPGRADE & PACKAGE LADDER

• 8.1 THE SIGNATURE DISTINCTION
• 8.2 THE UPGRADE & PACKAGE LADDER: ONE ECONOMICS, THREE TRACKS

9. COMPETITIVE LANDSCAPE AND CONTROL PLANES

• 9.1 FIVE SUB-BATTLEGROUNDS, NOT ONE AI MARKET
• 9.2 WHO ACTUALLY HOLDS THE CONTROL PLANES
• 9.3 EMBED VS PARTNER: THE OEM POSTURES, DATED

10. COMPANY SPOTLIGHTS

• Ultromics: the reimbursement front-runner
• Us2.ai: measurement ROI, vendor-agnostic
• UltraSight: the anti-embed guidance specialist
• Caption Health / GE HealthCare: guidance as platform glue
• Butterfly Network: the device-plus-OpEx proof point
• Echo IQ: reimbursement-oriented detection
• Exo: workflow-heavy handheld challenger
• BrightHeart: prenatal quality layer in the making
• Sonio / Samsung Medison: prenatal decision support, OEM-scaled
• Koios Medical: specialty decision support goes on-cart
• DiA Imaging Analysis / Philips: quantification absorbed into the platform
• AS Software: the under-digitized reporting lane
• 10.1 WATCH LIST

11. STRATEGIC PLAYBOOKS

• Systems OEMs
• Handheld / POCUS platforms
• AI software specialists
• Workflow / reporting vendors
• Providers and IDNs
• Investors and strategics

12. SIGNALS TO WATCH AND CLOSING SYNTHESIS

• 12.1 DATED SIGNPOSTS, NEXT 12–24 MONTHS
• 12.2 CLOSING SYNTHESIS